PHARMACYTE BIOTECH, INC. Commitments and Contingencies
PHARMACYTE BIOTECH, INC. (PMCB) had Commitments and Contingencies of $0 as of 2018-10-31, per its 10-Q filed 2018-12-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:CommitmentsAndContingencies · last filed 2018-12-14
- 2018-10-31: Commitments and Contingencies $0.00.
- 2018-07-31: Commitments and Contingencies $0.00.
- 2018-04-30: Commitments and Contingencies $0.00.
- 2014-04-30: Commitments and Contingencies $0.00.
| Period end | Commitments and Contingencies |
|---|---|
| 2018-10-31 | $0.00 10-Q · filed 2018-12-14 |
| 2018-07-31 | $0.00 10-Q · filed 2018-09-12 |
| 2018-04-30 | $0.00 10-Q · filed 2018-12-14 |
| 2014-04-30 | $0.00 10-Q · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |